Brady Barron was recently awarded an NIH F31, an Individual Predoctoral Fellows Award from the National Institute of Diabetes and Digestive and Kidney Diseases, which began on September 1, 2020. Brady is a Department of Pharmacology degree candidate in the lab of Kodi Ravichandran. He is studying the process of dead cell clearance in obesity, specifically identifying and characterizing previously unappreciated cell types and molecules, with the goal of manipulation for obesity and type 2 diabetes therapies.